首页> 美国卫生研究院文献>Springer Open Choice >Development of High Content Imaging Methods for Cell Death Detection in Human Pluripotent Stem Cell-Derived Cardiomyocytes
【2h】

Development of High Content Imaging Methods for Cell Death Detection in Human Pluripotent Stem Cell-Derived Cardiomyocytes

机译:高能成像技术在人类多能干细胞衍生心肌细胞死亡检测中的发展

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Human pluripotent stem cell-derived cardiomyocytes (hPSC-CM) are being investigated as a new source of cardiac cells for drug safety assessment. We developed a novel scalable high content microscopy-based method for the detection of cell death in hPSC-CM that can serve for future predictive in vitro cardio-toxicological screens. Using rat neonatal ventricular cardiomyocytes (RVNC) or hPSC-CM, assays for nuclear remodelling, mitochondrial status, apoptosis and necrosis were designed using a combination of fluorescent dyes and antibodies on an automated microscopy platform. This allowed the observation of a chelerythrine-induced concentration-dependent apoptosis to necrosis switch and time-dependent progression of early apoptotic cells towards a necrotic-like phenotype. Susceptibility of hPSC-CM to chelerythrine-stimulated apoptosis varied with time after differentiation, but at most time points, hPSC-CM were more resistant than RVNC. This simple and scalable humanized high-content assay generates accurate cardiotoxicity profiles that can serve as a base for further assessment of cardioprotective strategies and drug safety.Electronic supplementary materialThe online version of this article (doi:10.1007/s12265-012-9396-1) contains supplementary material, which is available to authorized users.
机译:人类多能干细胞衍生的心肌细胞(hPSC-CM)正在研究中,作为用于药物安全性评估的心肌细胞的新来源。我们开发了一种新颖的可扩展的高含量基于显微镜的方法,用于检测hPSC-CM中的细胞死亡,该方法可用于将来的预测性体外心脏毒理学筛查。使用大鼠新生儿心室心肌细胞(RVNC)或hPSC-CM,在自动显微镜平台上结合荧光染料和抗体,设计了核重塑,线粒体状态,凋亡和坏死的测定方法。这使得观察到白屈菜红碱诱导的浓度依赖性细胞凋亡向坏死转换,以及早期凋亡细胞向坏死样表型的时间依赖性进展。分化后,hPSC-CM对白屈菜红碱刺激的细胞凋亡的敏感性随时间而变化,但在大多数时间点,hPSC-CM的抗药性均高于RVNC。这种简单且可扩展的人源化高含量测定法可产生准确的心脏毒性特征,可作为进一步评估心脏保护策略和药物安全性的基础。电子补充材料本文的在线版本(doi:10.1007 / s12265-012-9396-1)包含补充材料,授权用户可以使用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号